Patents by Inventor Terumasa Hashimoto

Terumasa Hashimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG AND METHOD FOR TREATING OR PREVENTING COMPLICATIONS FROM DIABETES, USING SAID DRUG
    Publication number: 20220218664
    Abstract: A drug containing a compound represented by formula (I) as an active ingredient, used for complications from diabetes.
    Type: Application
    Filed: March 12, 2020
    Publication date: July 14, 2022
    Inventors: Keita Shibata, Ryosuke Shinouchi, Terumasa Hashimoto, Koji Nobe
  • Drug and Method of Treating or Preventing Renal Disease Using Drug
    Publication number: 20210000794
    Abstract: A drug for renal disease, the drug including a compound represented by the following Formula (I) as an active ingredient.
    Type: Application
    Filed: February 26, 2019
    Publication date: January 7, 2021
    Applicants: Showa University, TMS Co., Ltd.
    Inventors: Terumasa Hashimoto, Keita Shibata, Kazuo Honda, Koji Nobe
  • Cytoprotective agent
    Patent number: 9078880
    Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.
    Type: Grant
    Filed: February 5, 2010
    Date of Patent: July 14, 2015
    Assignees: National University Corporation Tokyo University of Agriculture and Technology, TMS Co., Ltd., Showa University
    Inventors: Kazuo Honda, Terumasa Hashimoto, Keita Shibata, Keiko Hasegawa, Keiji Hasumi
  • CYTOPROTECTIVE AGENT
    Publication number: 20120135996
    Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.
    Type: Application
    Filed: February 5, 2010
    Publication date: May 31, 2012
    Inventors: Kazuo Honda, Terumasa Hashimoto, Keita Shibata, Keiko Hasegawa, Keiji Hasumi
  • 3-(1H-tetrazol-5-y1)oxanilic acid and salts thereof and pharmaceutical compositions containing them
    Patent number: 4795754
    Abstract: A new compound, 3-(1H-tetrazol-5-yl)oxanilic acid and pharmaceutically acceptable salts thereof are herein disclosed, which can be prepared by reacting 3-(1H-tetrazol-5-yl)aniline with a compound represented by the general formula: A--CO--CO--B (wherein A and B may be identical with or different from one another and represent hydroxyl group, a halogen atom or a lower alkoxy group) and then optionally hydrolyzing the resultant product. The compound presents an excellent histamine and SRS-A release inhibitory effect and is hydrophilic or soluble in water. Therefore, the compound is very suitable to form, in particular, an aqueous pharmaceuticals for treatment or prevention of allergic diseases such as bronchial asthma, rhinitis and conjunctivitis.
    Type: Grant
    Filed: August 7, 1987
    Date of Patent: January 3, 1989
    Assignee: Wakamoto Pharmaceutical Co., Ltd.
    Inventors: Shohei Sawaki, Yasuhiro Ootake, Terumasa Hashimoto, Tooru Abe, Yoshihiro Horio
  • Anti-asthmatic composition and process for preparing the same
    Patent number: 4778816
    Abstract: 5-(3-n-Butyloxalylaminophenyl) tetrazole having an excellent SRS-A release-inhibiting effect is used as an effective component for an anti-asthmatic agent, and a pharmaceutical preparation obtained by mixing the tetrazole with a specific dispersant such as polysorbate-80 in coexistence with a non-aqueous solvent shows high dissolubility and bioavailability.
    Type: Grant
    Filed: September 17, 1985
    Date of Patent: October 18, 1988
    Assignee: Wakamoto Pharmaceutical Co., Ltd.
    Inventors: Tooru Abe, Yukiyoshi Yanagihara, Takao Shida, Shigekatsu Kohno, Katsuya Ohata, Yoshiaki Ogasawara, Shinji Kageyama, Touru Oguma, Yoshihiro Tsuriya, Toshio Kuroda, Terumasa Hashimoto
  • Cytoprotective agent
    Patent number: RE47684
    Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: November 5, 2019
    Assignee: TMS CO., LTD.
    Inventors: Honda Kazuo, Terumasa Hashimoto, Keita Shibata, Keiko Hasegawa, Keiji Hasumi
  • Cytoprotective agent
    Patent number: RE49351
    Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.
    Type: Grant
    Filed: September 26, 2019
    Date of Patent: January 3, 2023
    Assignee: Biogen MA Inc.
    Inventors: Kazuo Honda, Terumasa Hashimoto, Keita Shibata, Keiko Hasegawa, Keiji Hasumi